Myomo Reports First Quarter 2026 Financial and Operating Results
Revenue of $10.1 million with 49% of first quarter revenue from recurring patient sources MyoPro® orders received during the quarter were up 12% year-over-year Expanded gross margin, lower operating expenses and narrowed net loss Conference call begins at 4:30pm Eastern time today BURLINGTON, Mass. (May 7, 2026) – Myomo, Inc. (NYSE American: MYO) […]
Myomo Announces Availability of MyoPro at Ottobock Care Clinics in the U.S.
Burlington, Mass. (May 4, 2026) – Myomo, Inc. (NYSE American: MYO) a wearable medical robotics company and manufacturer of the MyoPro® powered arm brace announces expanded access to the MyoPro device through Ottobock Care clinics nationwide. Ottobock Care will offer the MyoPro through its clinics across the country, helping individuals with upper extremity impairment caused […]
Myomo to Report First Quarter 2026 Financial Results on May 7
BURLINGTON, Mass. (May 1, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2026 on Thursday, May 7, 2026. Management […]
Webinars
Myomo Webinar Series Stay Informed. Stay Connected. Stay Ahead. Join us for an exclusive three-part webinar series designed to equip clinicians, providers, and industry partners with the knowledge and tools to maximize the benefits of the MyoPro® 2x. Each session dives into a critical area to help you succeed—whether it’s navigating reimbursement, discovering what’s new, […]
Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference
Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference BURLINGTON, Mass (March 31, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer and […]
Myomo Receives Order from the Louis Stokes Cleveland VA Medical Center to Support MyoPro Clinical Trial
Dr. Svetlana Pundik of the Louis Stokes Cleveland VA Medical Center to lead the investigator-initiated study BOSTON, (August 30, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced receipt of a $120,000 order for […]
Myomo Reports Second Quarter 2022 Financial Results and Record Number of Patient Pipeline Additions
Second quarter revenue of $3.7 million up 18% over prior year Cost per pipeline addition cut in half over the last six months Conference call begins at 4:30 p.m. Eastern time today BOSTON (August 3, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those […]